Physician

Ryan Scott Owsley, MD

According to 2025 Medicare claims, Ryan Owsley, MD (NPI: 1659361681) practices dermatology in the Boise City, ID market, with the plurality of this provider's patient population coming from Canyon, ID. This provider's primary affiliated billing organization is COMPREHENSIVE DERMATOLOGY OF IDAHO, PLLC (NPI: 1386921294; TIN: 45-3568119) and primary practice location at 83687-9998.

Owsley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 570 traditional Medicare patients, billed 21,359 HCPCS/CPT codes, and received $278,444 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 739 prescription claims across 226 beneficiaries totaling $467,468 in drug costs, led by Humira Pen (Adalimumab). Open Payments data shows 62 records totaling $1,672. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $211,213 and ending at $467,468. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$159K$319K2015 Medicare payment: $318,749 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $295,214 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $313,567 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $289,122 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $269,771 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $255,444 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $279,422 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $255,884 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $264,192 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $278,444 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157626,985$318,749
20167928,017$295,214
20177968,284$313,567
20187449,288$289,122
201971712,713$269,771
202068711,112$255,444
202168613,647$279,422
202263214,251$255,884
202361115,093$264,192
202457021,359$278,444

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$266K$533K2015 Drug cost: $211,213 (USD; Tot_Drug_Cst)2016 Drug cost: $294,800 (USD; Tot_Drug_Cst)2017 Drug cost: $349,985 (USD; Tot_Drug_Cst)2018 Drug cost: $338,644 (USD; Tot_Drug_Cst)2019 Drug cost: $172,525 (USD; Tot_Drug_Cst)2020 Drug cost: $394,151 (USD; Tot_Drug_Cst)2021 Drug cost: $532,958 (USD; Tot_Drug_Cst)2022 Drug cost: $496,324 (USD; Tot_Drug_Cst)2023 Drug cost: $268,541 (USD; Tot_Drug_Cst)2024 Drug cost: $467,468 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015300804$211,213
2016259731$294,800
2017208570$349,985
2018226696$338,644
2019233633$172,525
2020266747$394,151
2021244757$532,958
2022246683$496,324
2023262707$268,541
2024226739$467,468

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths197289$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more257394$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more332465$53
17000Destruction of precancer skin growth, 1 growth328433$37
17003Destruction of precancer skin growth, 2-14 growths2892,197$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira PenAdalimumab11420$101,265
Dupixent SyringeDupilumab14644$79,408
OtezlaApremilast12360$59,444
Doxycycline HyclateDoxycycline Hyclate662,767$2,211
Clobetasol PropionateClobetasol Propionate361,205$1,532

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.62$1,672ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ryan Scott Owsley, MD?

Tedicare shows public-source Medicare data for Ryan Scott Owsley, MD (NPI 1659361681), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan Scott Owsley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan Scott Owsley, MD?

Ryan Scott Owsley, MD is linked to COMPREHENSIVE DERMATOLOGY OF IDAHO, PLLC (billing NPI 1386921294) in the available physician profile data.

Does Ryan Scott Owsley, MD have Open Payments data?

Ryan Scott Owsley, MD has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.